History

전체메뉴

2022.09
Obtained certification and permission from the Ministry of Food and Drug Safety for Endoscopic Linear Stapler & Novel Asymmetrical Linear Stapler (NALS) (Endo Blossom 7 cases and Endo Blossom NALS 10 cases)
2022.07
Domestic Exclusive Sales Contract for Endoscopic Linear Stapler & Novel Asymmetrical Linear Stapler (NALS) (Dong-A ST)
2022.06
MEDITULIP obtained additional GMP certification (Surgical devices)
2022.03
Secured investments of KRW 3.0 billions from Korean venture capitals

2019.07
TULIP PORT obtained approval from the Korean Ministry of Food & Drug Safety
2019.05
MEDITULIP obtained GMP certificatation
2019.01
Completion of the Meditulip Production Facility (GMP)

2017.07
Selected as a beneficiary of U-TECH Valley loan program as the first among national universities
2017.01
MEDITULIP Research Center was certified

2016.12
Established a branch office in Shanghai, China
2016.12
Obtained approval of moving into the land of Osong bio-Health Science Technopolis.
2016.10
Secured investments of KRW 1.5 billions from Korean venture capitals
2016.07
Agreed an investment contract with Chungcheongbuk-do along with Medical venture companies.
2016.05
Appeared on SBS CNBC 'The Eye of Enterprise that sees the Future Leader'

2015.12
Obtained a new technology patent for a surgical stapler that can secure tissues for pathological examination
2015.09
Selected as a Chungbuk Industry–University Cooperation R&D Enterprise and for the TIPS program (first case for a company established by a national university faculty), and certified as a venture firm
2015.08
Opened the Osong office of Meditulip Co., Ltd.: Moved into the Osong Bio-Health Science Technopolis and qualified for various benefits under the Enforcement Decree of the Special Act on the Designation and Support of High-tech Medical Complexes (Presidential Decree No. 24454, March 23, 2013)
2015.04
Founded Meditulip Co., Ltd., a corporation established by a university faculty